Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of teriparatide on skeleton images in
postmenopausal women with osteoporosis. Teriparatide is a bone formation agent that
stimulates the production of new bone in the skeleton. This process of bone formation can be
studied using a technique commonly referred to as a bone scan or nuclear scintigraphy. This
trial will test whether bone scans will identify areas of the skeleton that are forming new
bone during teriparatide therapy. It also will study what these areas look like after therapy
is stopped.